CSP Medical Store - IBt Bebig Presents Its New HDRplus 3.0 at ESTRO
IBt Bebig has announced today that it released its new version of the treatment planning HDRplusTM 3.0 at the ESTRO International Oncology Forum held in London on May 8-12, 2011.
London, Canada, May 17, 2011 --(PR.com)-- IBt Bebig has announced today that it released its new version of the treatment planning HDRplusTM 3.0 at the ESTRO International Oncology Forum held in London on May 8-12, 2011.
The HDRplus(TM) is an innovative software program for precise and efficient HDR (High Dose Rate) treatment planning. It provides its users with functions that considerably simplify and speed up their plan preparation. The software delivers an optimized treatment plan and makes the process especially fast, flexible and precise. The user interface features a modern and easy-to-use structure, including many possibilities to customize the layout and parameter settings. This allows the user to tailor the system to his own workflow.
HDRplus(TM) software supports all HDR applications, including intraluminal, interstitial, intracavitary, intra-operative und surface mould treatments. An optional Prostate Module permits real time online planning using transversal and longitudinal TRUS (Transrectal Ultrasonography). HDRplus(TM) has a complete applicator database which shortens the work flow and minimizes possibilities of human errors.
Further functionalities have been implemented in version 3.0 of HDRplus(TM) in order to speed up the treatment planning process: Automatic catheter tracking and automatic image fusion of different image modalities like US (Ultrasound Imaging), CT (Computed Tomography), MRI (Magnetic Resonance Imaging) and PET (Positron Emission Tomography) are now supported. Improved DICOM 3 and DICOM RT network functionality offers the customer to share the information with other systems.
"IBt Bebig continues to innovate in the world of Brachytherapy as our goal is to bring the most efficient products for the benefits of patients and medical practitioners. We are proud to be the first company in the world to release a software calculating biological effective doses for the combined treatment of EBRT (External Beam Radio Therapy) and Brachytherapy. Our new HDRplus(TM) offers also the Automatic Image Fusion that enables users to match CT and MR images without any necessary interaction in less than 30 seconds," said Dr. Edgar Löffler, Managing Director of IBt Bebig. "We react on the current market needs and we support other vendor of afterloader system protocols as well with our new software. This allows for further market expansion."
CSP Medical is the distributor of iBt Bebig products in Canada.
About IBt Bebig
The IBt Bebig group is a European based group, active in the Medical Device segment of the Health Care sector.
The core business of the IBt Bebig group is the cancer treatment by radiation technology. Its specificity is the treatment of cancer by brachytherapy, a technique which consists of placing a sealed medical device containing a minuscule quantity of a radioactive isotope in the body, on either a temporary or on a permanent basis. Depending on the application, the device can take the shape of a plaque, a seed or a catheter. The precise positioning of the device allows the cancer cells to be destroyed while sparing the healthy tissues and increasing the patient's quality of life. Today, the alternative brachytherapy procedures cover the non-invasive treatment of cancers of the prostate, neck, head and eye, as well as certain gynecological cancers.
About CSP Medical:
CSP Medical is a North American distributor representing over 100 manufacturers. CSP Medical specializes in: radiation therapy, medical physics, x-ray, nuclear medicine & PET, mammography, ultrasound, CT and MRI. For more information, visit www.cspmedical.com.
For Canadian Media inquiries:
Leela Sharma, Marketing & Communications leela@cspmedical.com 800.265.3460 ext 33
###
The HDRplus(TM) is an innovative software program for precise and efficient HDR (High Dose Rate) treatment planning. It provides its users with functions that considerably simplify and speed up their plan preparation. The software delivers an optimized treatment plan and makes the process especially fast, flexible and precise. The user interface features a modern and easy-to-use structure, including many possibilities to customize the layout and parameter settings. This allows the user to tailor the system to his own workflow.
HDRplus(TM) software supports all HDR applications, including intraluminal, interstitial, intracavitary, intra-operative und surface mould treatments. An optional Prostate Module permits real time online planning using transversal and longitudinal TRUS (Transrectal Ultrasonography). HDRplus(TM) has a complete applicator database which shortens the work flow and minimizes possibilities of human errors.
Further functionalities have been implemented in version 3.0 of HDRplus(TM) in order to speed up the treatment planning process: Automatic catheter tracking and automatic image fusion of different image modalities like US (Ultrasound Imaging), CT (Computed Tomography), MRI (Magnetic Resonance Imaging) and PET (Positron Emission Tomography) are now supported. Improved DICOM 3 and DICOM RT network functionality offers the customer to share the information with other systems.
"IBt Bebig continues to innovate in the world of Brachytherapy as our goal is to bring the most efficient products for the benefits of patients and medical practitioners. We are proud to be the first company in the world to release a software calculating biological effective doses for the combined treatment of EBRT (External Beam Radio Therapy) and Brachytherapy. Our new HDRplus(TM) offers also the Automatic Image Fusion that enables users to match CT and MR images without any necessary interaction in less than 30 seconds," said Dr. Edgar Löffler, Managing Director of IBt Bebig. "We react on the current market needs and we support other vendor of afterloader system protocols as well with our new software. This allows for further market expansion."
CSP Medical is the distributor of iBt Bebig products in Canada.
About IBt Bebig
The IBt Bebig group is a European based group, active in the Medical Device segment of the Health Care sector.
The core business of the IBt Bebig group is the cancer treatment by radiation technology. Its specificity is the treatment of cancer by brachytherapy, a technique which consists of placing a sealed medical device containing a minuscule quantity of a radioactive isotope in the body, on either a temporary or on a permanent basis. Depending on the application, the device can take the shape of a plaque, a seed or a catheter. The precise positioning of the device allows the cancer cells to be destroyed while sparing the healthy tissues and increasing the patient's quality of life. Today, the alternative brachytherapy procedures cover the non-invasive treatment of cancers of the prostate, neck, head and eye, as well as certain gynecological cancers.
About CSP Medical:
CSP Medical is a North American distributor representing over 100 manufacturers. CSP Medical specializes in: radiation therapy, medical physics, x-ray, nuclear medicine & PET, mammography, ultrasound, CT and MRI. For more information, visit www.cspmedical.com.
For Canadian Media inquiries:
Leela Sharma, Marketing & Communications leela@cspmedical.com 800.265.3460 ext 33
###
Contact
CSP Medical Store
Leela Sharma
1-800-265-3460
www.cspmedicalstore.com
For Media inquiries:
Leela Sharma, Marketing & Communications leela@cspmedical.com 800.265.3460 ext 33
Leela Sharma
1-800-265-3460
www.cspmedicalstore.com
For Media inquiries:
Leela Sharma, Marketing & Communications leela@cspmedical.com 800.265.3460 ext 33
Contact
Categories